Celltrion marks decade of biosimilar innovation in Europe with new campaign
Celltrion Healthcare has launched a new campaign to celebrate a decade of biosimilar innovation in Europe.
Source: biopharma-reporter.com
Page 42 - Bio Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bio Developments Today - Breaking & Trending Today
Vaxess announces $9 million funding for mRNA vaccine patch
Vaxess Technologies, a life sciences company developing a shelf-stable vaccine patch with potential for self-application, has announced an additional $9 million in venture capital funding, with investors including RA Capital, The Engine, and GHIC, and Ulu Ventures.
Source: biopharma-reporter.com
Mission Bio launches genome editing solution for Advanced Therapies
Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, has launched its new Tapestri Genome Editing Solution.
Source: biopharma-reporter.com
Kuano raises £1.8 million to accelerate quantum drug discovery
Kuano, a drug discovery company combining quantum mechanics with AI, has announced the close of its £1.8 million seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors.
Source: biopharma-reporter.com
Arrowhead highlights potential of RNAi in asthma at ERS 23
Arrowhead Pharmaceuticals has spotlighted the potential of RNA interference (RNAi) therapeutic candidates in the lungs, with a clinical late breaker and multiple pre-clinical presentations at this year’s European Respiratory Society (ERS) International Congress 2023 in Milan, Italy.
Source: biopharma-reporter.com